Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

BACKGROUND: Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. METHODS: In the present study we investigated the predictive value...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilskog, Martin, Beisland, Christian, Akslen, Lars A., Bostad, Leif, Haug, Åse, Heinrich, Daniel, Hjelle, Karin M., Straume, Oddbjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580299/
https://www.ncbi.nlm.nih.gov/pubmed/28859644
http://dx.doi.org/10.1186/s12894-017-0267-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580299/
https://www.ncbi.nlm.nih.gov/pubmed/28859644
http://dx.doi.org/10.1186/s12894-017-0267-6

Ejemplares similares